promomed
Skyvira
Skyvira
Skyvira is the latest Russian etiotropic combined drug from Promomed Group for the treatment of mild or moderate coronavirus infection in adults, including patients with a risk of developing more severe forms of the disease.
Name Skyvira
Dosage form Film-coated tablets.
Active agent

Each tablet contains:

Nirmatrelvir 300.0 mg

Ritonavir 100.0 mg

Skyvira will help defeat the virus, prevent the development of complications and minimize the post-COVID syndrome in patients with concomitant chronic diseases.

Skyvira inhibits the enzyme of the SARS-CoV-2 virus responsible for reproduction, thereby disrupting the reproduction process of the virus in a cell, and as a result:

  • in 86% of patients, the risk of hospitalization and severe course of the disease is reduced,

  • already on the 5th day of therapy, the viral load decreases tenfold.

Skyvira is a unique combination in one tablet that destroys coronavirus!

The drug is used 1 tablet twice daily (every 12 hours) for 5 days after consultation with a doctor.


An open, two-stage, multicenter study to evaluate the main pharmacokinetic parameters, safety, and efficacy against COVID-19 of Skyvira (PROMOMED RUS LLC, Russia) in the adult population/2022.

Prescription product. Consult a doctor before use.